Skye Bioscience, Inc. SKYE 深 滬
等待開盤 07-23 09:30:00 美东时间
3.855
+0.125
+3.35%
華盛通- 最 高4.03
- 今 開3.66
- 成交量 45.46万股
- 最 低 3.46
- 昨 收 3.73
- 總市值 1.19亿
- 52周最高 7.47
- 市盈率 靜 --
- 換手率 1.47%
- 52周最低 1.14
- 委 比 0.00%
- 總股本 3098.44万
- 歷史最高 17.6473
- 量 比 1.26
- 振 幅 15.28%
- 歷史最低 1.14
- 每 手 1
- 風險率 3.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 纳比特大涨超36%，公司宣布为币安币储备大额可转换票据；内克塔治疗飙升逾150%
纳比特大涨超36%，公司宣布为币安币储备大额可转换票据；内克塔治疗飙升逾150%，皮炎药物临床试验结果良好；安霸拟考虑出售公司，隔夜涨超20%>>
06-25 19:15
美股大行评级 | 潜在涨幅390.8%！HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级
多家机构首予Amrize买入评级，目标价53~62美元；HC Wainwright & Co.上调内克塔治疗目标价至120美元，维持"买入"评级>>
06-25 08:39
JMP Securities Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target
JMP Securities analyst Jonathan Wolleben reiterates Skye Bioscience (NASDAQ:SKYE) with a Market Outperform and maintains $15 price target.
06-24 21:47
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
Skye Bioscience, a biotech company focused on metabolic health, will present new data on its CB1 inhibitor nimacimab at the ADA 85th Scientific Sessions in Chicago (June 20-23, 2025). The company will participate in multiple forums, including an Evercore panel, a symposium presentation on nimacimab's mechanistic insights in obesity, and a poster presentation highlighting its effects in diet-induced obesity mouse models. Nimacimab, a peripherally-...
06-17 11:00
Brand Engagement Network Taps Hospitality Market With AI Concierge at The Dvin Resort
Brand Engagement Network Inc. (BEN) (NASDAQ:BNAI), an innovator in AI-powered customer engagement, announced it has entered into a formal agreement with Seven Visions Resort & Places, The Dvin (The Dvin), to develop
05-15 18:07
Skye Bioscience Q1 2025: Progress in Obesity Treatment
Skye Bioscience, Inc. ( ($SKYE) ) has released its Q1 earnings. Here is a break...
05-09 13:52
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
美股大行评级 | 高盛：上调Adaptive Biotechnologies评级至"买入"，目标价从8美元升至9美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1110125309827231744.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Oppenheimer：维持Amprius Technologies(AMPX)"跑赢大市"评级，目标价从14美元升至15美元</p> <p>• 韦德布什：维持Monte Rosa Therapeutics(GLUE)"跑
03-24 07:31
Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress
Skye Bioscience, Inc. (($SKYE)) has held its Q4 earnings call. Read on for the ...
03-22 08:31
Earnings Scheduled For March 20, 2025
Companies Reporting Before The Bell • Star Equity Hldgs (NASDAQ:STRR) is projec...
03-20 16:32
